This inventor holds 44 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 14 EPO patents, primarily in Organic Chemistry. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limitjed. Active years: 1996-2023.
Location History:
- Ibaraki, JP (2000 - 2009)
- Osaka, JP (1996 - 2023)
Company Filing History:
31 out of 1,226 
12 out of 1,858 
1 out of 1 Years Active: 1996-2023
Areas of Expertise:
Title: Innovations by Tsuneo Yasuma: A Journey Through Patents and Collaborations
Introduction
Tsuneo Yasuma, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 44 patents. His work primarily focuses on the synthesis and development of novel compounds that serve as potential treatments for cancer and other disorders associated with cell proliferation.
Latest Patents
Among Tsuneo Yasuma's recent innovations are two notable patents involving the compound 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate. The first patent details the crystalline forms of this compound, including processes for their preparation, pharmaceutical compositions, and methods for inhibiting cell division cycle 7 in mammals. These advancements offer new avenues for treating cell division cycle 7-mediated cancers. Another patent highlights the synthesis processes of the same compound and its derivatives, emphasizing their use as Cdc7 kinase inhibitors for combating disorders of cell proliferation, particularly cancer.
Career Highlights
Throughout his career, Tsuneo Yasuma has collaborated with prominent companies, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His innovative work in the pharmaceutical sector has positioned him as a key figure in the development of therapeutic agents aimed at critical health challenges.
Collaborations
Collaboration has been an integral aspect of Tsuneo Yasuma's professional journey. He has worked alongside notable colleagues such as Nobuyuki Negoro and Akira Mori, who have contributed to enhancing the scope and impact of his research. These partnerships may have played a vital role in the successful development of his patented compounds.
Conclusion
Tsuneo Yasuma exemplifies the spirit of innovation within the pharmaceutical industry, with his substantial portfolio of patents reflecting his commitment to advancing medical science. His pioneering work continues to impact the methodology of cancer treatment and the study of cellular processes. As the field advances, Yasuma's contributions will undoubtedly remain influential in shaping future breakthroughs.